
1265: Ear Trumpet
Kodak Insider Trading and Hydroxychloroquine Regulatory Shifts
Allegations of insider trading at Kodak are discussed following a $765 million government loan announcement for pharmaceutical production. Meanwhile, the Ohio Board of Pharmacy withdrew its ban on hydroxychloroquine prescriptions for COVID-19. FDA Commissioner Stephen Hahn is heard on The Today Show clarifying that the FDA does not regulate the practice of medicine and that the use of the drug remains a private decision between doctors and patients.






